Korea's First Medical Export

The history of CHA Medical Group’s medical export is the history of Korea’s medical export.

October 2014 Tokyo Cell Clinic (Tokyo, Japan)

Tokyo Cell Clinic, the first medical institution exported by CHA Medical Group to Japan, is located in New Pier Takeshiba South Tower, Tokyo and specializes in immunocyte treatment. Tokyo Cell Clinic was founded to help people suffering from diseases caused by a weakened immune system (e.g. using immunocyte therapy (AKC immunotherapy) to treat cancer).

Tokyo Cell Clinic has state-of-the-art cell processing facilities complying with good manufacturing practices (GMP) for high quality cell processing, which is most important in immunocyte therapy. Its advanced facilities separate and culture cells as soon as a patient’s blood is collected. Tokyo Cell Clinic manages cell quality hygienically and complies with International standards, so that everyone who receives treatment will have peace of mind.
HOMEPAGE

November 2004 CHA Hollywood Presbyterian Medical Center (Los Angeles, U.S.)

CHA Hollywood Presbyterian Medical Center, acquired by CHA Health Systems in 2004, is the first general hospital in the U.S. owned and operated by a Korean company. It is an exemplary case of globalization for the Korean medical business. CHA Hollywood Presbyterian Medical Center is composed of seven buildings with a total surface area of 30,000-pyeong (356 Thousand Square feet), approximately 600 medical professionals and 1,500 employees.
HOMEPAGE

July 2002 Founded LA Frozen Egg Bank

At the world’s first private frozen egg bank, LA Frozen Egg Bank rapidly freezes healthy oocytes and
keeps them at extremely low temperatures. When a client wants to become pregnant, it unfreezes
her oocyte for pregnancy. Unlike sperm banks which provide general services, egg banks require
much more sophisticated technology.

After 20-years of effort to create stable ‘human egg freezing technology,’ CHA Medical Group has
finally developed the world’s first ‘oocyte cryopreservation by vitrification’ in 1998. In 2005, CHA
Medical Group developed ‘oocyte cryopreservation using slush nitrogen’ which improved the
survival rate to 90%. Due to its advanced medical technologies, CHA group has been globally
recognized for its technical expertise and efficiency.

February 2002 Opened CHA Fertility Center in Los Angeles

CHA Fertility Center Los Angeles set a new precedent by shifting the paradigm of Korean
medicine, which was limited to Korean medical circles to expansion into foreign medical
markets. It was recognized by local media as a splendid achievement that demonstrated
the promise of Korean medicine.
HOMEPAGE

May 1999 Opened Cha-Columbia Fertility Center in New York

CHA Medical Group, recognized as a world class authority in global medical
circles with its state-of-the-art technology for infertility treatment,
opened Cha-Columbia Fertility Center in association with Columbia
University’s Department of Obstetrics and Gynecology in May 1999.

This remarkable achievement was realized thanks to CHA Medical Group’s
research infrastructure, advanced research, and outstanding technology.
It remains a case example of successfully exporting Korean medical
technology to the U.S., a nation at the forefront of advanced medicine.
Chairman Kwang-yul Cha served as an exchange professor for Columbia
University’s Department of Obstetrics and Gynecology.

scroll to top button